BidaskClub upgraded shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) from a strong sell rating to a sell rating in a report issued on Saturday.

AVDL has been the subject of several other reports. Zacks Investment Research cut Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from a hold rating to a sell rating in a research report on Monday, October 16th. Langenberg & Company reiterated a buy rating and set a $30.00 price target (up from $27.00) on shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share in a research report on Thursday, September 7th. Finally, Ladenburg Thalmann Financial Services boosted their price target on Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from $27.00 to $30.00 in a research report on Thursday, September 7th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the stock. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share currently has a consensus rating of Hold and a consensus price target of $21.75.

Shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) traded up $0.05 on Friday, hitting $8.93. The company had a trading volume of 456,338 shares, compared to its average volume of 385,631. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.53 and a quick ratio of 1.47. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share has a 52-week low of $7.52 and a 52-week high of $12.30. The stock has a market capitalization of $357.95, a PE ratio of 16.54 and a beta of 1.34.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) last issued its quarterly earnings results on Wednesday, November 8th. The company reported $0.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.13. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share had a return on equity of 33.92% and a net margin of 44.47%. The firm had revenue of $39.68 million during the quarter, compared to analysts’ expectations of $38.22 million. During the same period in the previous year, the business earned ($0.08) earnings per share. The firm’s revenue for the quarter was up 23.7% on a year-over-year basis. sell-side analysts predict that Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share will post 0.28 EPS for the current year.

In related news, insider Phillandas T. Thompson bought 5,000 shares of the company’s stock in a transaction on Wednesday, September 13th. The stock was bought at an average cost of $9.36 per share, for a total transaction of $46,800.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Craig R. Stapleton bought 20,000 shares of the company’s stock in a transaction on Tuesday, September 12th. The stock was bought at an average price of $9.52 per share, with a total value of $190,400.00. Following the completion of the acquisition, the director now owns 507,678 shares in the company, valued at $4,833,094.56. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 46,855 shares of company stock valued at $445,058. 5.07% of the stock is owned by company insiders.

Large investors have recently modified their holdings of the business. PNC Financial Services Group Inc. grew its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 2,484.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 10,956 shares of the company’s stock valued at $121,000 after buying an additional 10,532 shares in the last quarter. Nine Chapters Capital Management LLC purchased a new stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share in the 3rd quarter valued at $132,000. Sei Investments Co. grew its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 29.5% in the 2nd quarter. Sei Investments Co. now owns 12,726 shares of the company’s stock valued at $140,000 after buying an additional 2,900 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share in the 2nd quarter valued at $181,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share in the 3rd quarter valued at $184,000. Institutional investors own 67.81% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.watchlistnews.com/avadel-pharmaceuticals-plc-american-depositary-shares-each-representing-one-ordinary-share-avdl-upgraded-by-bidaskclub-to-sell/1756130.html.

About Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to commercialize differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results.

Receive News & Ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.